Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Date

 Thursday,  

Time

1:00pm - 2:00pm Pacific

3:00pm - 4:00pm Central

4:00 pm - 5:00 pm Eastern

Join Zoom Meeting
https://stanford.zoom.us/j/620526320

Meeting ID: 620 526 320

One tap mobile
+16507249799,,620526320# US
+18333021536,,620526320# US Toll-free

Dial by your location
+1 650 724 9799 US
+1 833 302 1536 US Toll-free
Meeting ID: 620 526 320
Find your local number: https://zoom.us/u/abhuQ90fRl

Join by SIP
620526320@zoomcrc.com


Attendees

Goals

TimeItemWhoNotes
 

Discuss review and action items for SE

  • SE thought that the L2 templates were intended to be breakout talks. IPO is adjusting talks.
  • Safety and QA policies are dependent on the lead lab, need to be careful about presenting this. Instead consider what these will address.
  • As we understand it, you are taking care of QA and safety. We suggest that he should provide L2s with a statement (general understanding) for QA and safety.

All 
 

DOE IPR Review Timeline

Requirements: suggested slides provided by SE

1 slide: discussing the process and where we are at + an eye chart of the reqs

1 slide: top 5 driving requirements

Note: SE team would like access to the L2 breakout talks to help with consistency

ICDs: ICD boundaries should be better defined and documents are incomplete and scattered

All 
 Path to CD-1, DR2020_SE_pathtoCD1.pptxAll 
 SEMP review and comments - please provide comments by next meeting? This shouldn't be released and finalized until a lead lab is chosen.Kurita 
5Agenda suggestions for next meetingAll

 

5AOB

All

 

Requirements Workbook for L2 Meetings

SE CD-1 deliverables

SE plans from LSSTCam  File Folder

ICD Folder

LSST-n-square.pptx

Agenda for DR:  https://docs.google.com/spreadsheets/d/12eM3wKnj-brY1XLPMEVLwv0oEdiyQ8puieTK_xONGX0/edit#gid=0

SE slides for L2s

SE presentation

 

Action items

  •